# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
https://www.wsj.com/health/healthcare/medicare-will-recalculate-quality-ratings-of-medicare-advantage-plans-eebee409?mod=latest...
Cantor Fitzgerald analyst Sarah James reiterates Cigna Group (NYSE:CI) with a Overweight and maintains $400 price target.
- Goldman Sachs Conf
- Goldman Sachs Conf
- Goldman Sachs Conf
- Goldman Sachs Conf
- Goldman Sachs Conf
- Goldman Sachs Conf
Humira maintains over 80% of its market share despite facing nine biosimilar rivals, raising concerns about the future of the b...